Views: 0 Author: Site Editor Publish Time: 2022-01-05 Origin: Site
Recently, South Africa and other countries have found new crown virus variants OMICRON (O'Koi), causing global concerns.
At 11:00, November 26, 2021, the World Health Organization issued a statement: the latest OMICRON variant strain B.1.1.529 is smaller than other variants.Have higher re-infection risk. B.1.1.52950 mutations，32 mutations on the thorn proteinThe number of mutations is twice the Delta virus. In recent weeks, South African infection has increased dramatically, most cases detected B.1.1.529 variability, and has quickly spread to Asia, Europe.
Comparative chart of Delta strain and O'Kek's thorn protein mutant (picture from Roman Children's Hospital)
When the OMICRON variant strain occurs, the test results appear more orf1ab gene single positive, resulting in timely discovery of OMICRON variant infection, and block propagation cannot be blocked in time. Tianlong Technology independently developed series new crown nucleic acid detection reagentDetect target coverageORF1AB/ RDRP, E, N gene，In detectionOmicronWhen variating strains,Effectively avoid the risk of slaughter and missed inspection,Nucleic acid detection can be completed in about 40 minutes, and the spread of the virus will be blocked.
The existing Tianlong new crown testing agent can also cover common new crown branch strains, such as Delta variant strains (i.e., India B.1.617.2) and British B1.1.7, etc., greatly reduce the possibility of missed inspection. In addition, in the face of a severe new new crown epidemic, Tianlong Technology can provide the overall solution of new crown nucleic acid detection, covering a full set of equipment, reagents and overall programs such as sample collection, nucleic acid extraction, nucleic acid detection and laboratory construction, and more than 70 worlds. Applications in countries and regions.
Program products have also obtained EU CE authority certification, US FDA, Netherlands, Ukraine, Kazakhstan, Indonesia and other national registration certificates, is an effective \"weapon \" of auxiliary diagnosis of new coronal pneumonia.
Tianlong Technology will continue to pay attention to the international new crown virus variability to ensure the detection of the reagents on the current main epidemic virus strain, while ensuring the specificity, accuracy and sensitivity of the reagent, and contribute to the international epidemic prevention and control contribution.
Tianlong Technology is based on market-oriented, and has been based on the research and development of science and technology, and pursues independent brands.